TY - JOUR
T1 - Serotonin and mental disorders
T2 - A concise review on molecular neuroimaging evidence
AU - Lin, Shih Hsien
AU - Lee, Lan Ting
AU - Yang, Yen Kuang
N1 - Publisher Copyright:
Copyright© 2014, Korean College of Neuropsychopharmacology
PY - 2014/12/1
Y1 - 2014/12/1
N2 - Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmacological treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.
AB - Serotonin is one of the most important neurotransmitters influencing mental health and, thus, is a potential target for pharmacological treatments. Functional neuroimaging techniques, such as positron-emission tomography (PET) and single photon emission computed tomography (SPECT), could provide persuasive evidence for the association between mental disorders and serotonin. In this concise review, we focus on evidence of the links between serotonin and major depressive disorders, as well as other mood disorders, anxiety disorders, schizophrenia, addiction, attention deficit hyperactivity disorder (ADHD), and autism.
UR - http://www.scopus.com/inward/record.url?scp=84919959094&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919959094&partnerID=8YFLogxK
U2 - 10.9758/cpn.2014.12.3.196
DO - 10.9758/cpn.2014.12.3.196
M3 - Article
AN - SCOPUS:84919959094
SN - 1738-1088
VL - 12
SP - 196
EP - 202
JO - Clinical Psychopharmacology and Neuroscience
JF - Clinical Psychopharmacology and Neuroscience
IS - 3
ER -